Vivos Therapeutics, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+3.4% +$126K
$4M
Cost of Revenue↓-47.8% -$765K
$836K
Gross Profit↑+42.5% +$891K
$3M
R&D
$100K
SG&A
—
D&A↑+206.9% +$298K
$442K
Operating Income↓-79.0% -$2M
$-5M
EBITDA↑+206.9% +$298K
$442K
Interest Expense
$800K
Interest Income
—
Other Income/Expense↓-672.4% -$195K
$-166K
Pretax Income↓-106.4% -$3M
$-5M
Net Income↓-106.4% -$3M
$-5M
Gross Margin↑+21.4pts
78.1%
Operating Margin↓-1.3pts
-69.8%
Net Margin↓-11.8pts
-79.6%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory
—
ETR State + Local (pp)↓-0.7pts
-3.0%
Operating Lease Cost↑+495.5% +$555K
$667K
Revenue YoY Variation↓-10.4pts
3.4%
Income YoY Variation↓-106.3pts
-79.0%
Revenue QoQ Variation↓-39.4pts
-43.6%
Income QoQ Variation↑+39.3pts
2.7%